Background-A model using administrative claims data that is suitable for profiling hospital performance for heart failure would be useful in quality assessment and improvement efforts. Methods and Results-We developed a hierarchical regression model using Medicare claims data from 1998 that produces hospital risk-standardized 30-day mortality rates. We validated the model by comparing state-level standardized estimates with state-level standardized estimates calculated from a medical record model. To determine the stability of the model over time, we used annual Medicare cohorts discharged in 1999 -2001. The final model included 24 variables and had an area under the receiver operating characteristic curve of 0.70. In the derivation set from 1998, the 25th and 75th percentiles of the risk-standardized mortality rates across hospitals were 11.6% and 12.8%, respectively. The 95th percentile was 14.2%, and the 5th percentile was 10.5%. In the validation samples, the 5th and 95th percentiles of risk-standardized mortality rates across states were 9.9% and 13.9%, respectively. Correlation between risk-standardized state mortality rates from claims data and rates derived from medical record data was 0.95 (SEϭ0.015). The slope of the weighted regression line from the 2 data sources was 0.76 (SEϭ0.04) with intercept of 0.03 (SEϭ0.004). The median difference between the claims-based state risk-standardized estimates and the chart-based rates was Ͻ0.001 (25th percentileϭϪ0.003; 75th percentileϭ0.002). 
atients with heart failure, the most common cause of admission among Medicare beneficiaries, 1 have a high risk of mortality. 2, 3 Current publicly reported process measures for assessing heart failure care are quite limited 4 and may fail to discriminate between healthcare providers on the basis of their overall quality of heart failure care. The direct measurement of healthcare outcomes may complement efforts to characterize performance by process measures. 5 Although some variation in outcome is beyond the control of clinicians and hospitals, quality of care and safety would be expected to influence the risk of adverse events in these patients.
Clinical Perspective p 1701
To use outcomes as an indicator of healthcare performance in the care of patients with heart failure requires statistical methods that can evaluate the comparative performance of regions, health systems, and hospitals, taking into account any differences in case mix. Such statistical models should have several key attributes. 6 First, the model and its performance should be in the public domain so that it can be properly evaluated by the groups it is assessing. Second, because the spectrum of patients may vary among regions and institutions, the model must adjust for differences in demographic and clinical characteristics. Third, the model should use an approach that is appropriate for the hierarchical organization of the data (eg, patients nested within institutions). Finally, the model ideally should be properly validated in different populations of patients and across organizations and institutions to which it will be applied. Moreover, for efforts using administrative claims data, which have limitations but are the only source of information for national profiling, validation should ideally include a comparison with statistical models that use higher-quality clinical data. The focus of the comparison should be on the output of the models with respect to characterizing performance at the organizational level rather than patient-level discrimination.
Our objective was to develop a statistical model based on administrative claims data that would be appropriate to profile hospitals, regions, and states by their 30-day mortality rates for patients admitted with a diagnosis of heart failure. Because medical record data were only available in sufficient numbers to perform a state-level comparison of the output of the 2 models, we determined whether the state estimates of risk-standardized mortality rates from the claims model could be used as surrogates for the results of the medical record model. We also evaluated the stability of the model over time.
Methods

Derivation and Validation Cohorts
The Derivation Cohort
We randomly sampled half of the hospitalizations for heart failure ( For risk adjustment we used information contained in the MEDPAR files, physician files, and hospital outpatient files. The MEDPAR claims have data on each hospitalization for fee-for-service Medicare enrollees and include demographic information, principal and secondary diagnosis codes, and procedure codes. Diagnosis codes for comorbidities were also collected from physician and hospital outpatient files. These data were collected for the year before the index hospitalization.
We retained hospitalizations in which the patient was aged Ն65 years because these patients are representative of the older heart failure population and had at least 1 year of Medicare utilization data before their hospitalization. For patients who were transferred, we linked the hospitalizations into an episode of care. The information about the patient was derived from the hospital to which the patient was initially admitted. The initial hospital was also designated as the responsible institution for the episode.
We excluded patients who were not in fee-for-service Medicare for 1 year before their admission. For patients with multiple admissions during the study period, we randomly selected a hospitalization. We also excluded patients who were discharged alive and not against medical advice with a total length of stay Յ1 day because it is unlikely that these patients were admitted with decompensated heart failure.
The Validation Cohorts
The primary validation was a comparison of risk-standardized mortality rates between the claims model and the medical record model. To conduct this comparison, we constructed a linked sample that contained both claims and medical chart abstracted data from the National Heart Care (NHC) Project, a national heart failure quality improvement project sponsored by the Centers for Medicare & Medicaid Services (CMS). 7 The first NHC sample included hospitalizations with a principal discharge diagnosis of heart failure between April 1998 and March 1999, inclusive, and the second between July 2000 and June 2001, inclusive. In both time periods, all identified discharged patients in each of the 50 states, Washington, DC, and Puerto Rico were sorted by age, sex, race, and hospital. Within each state, up to 800 discharges in each of the 2 sampling frames were randomly selected; a census of records was obtained in states with Ͻ800 eligible discharged patients. Records were reviewed in central data abstraction centers for clinical data. Data quality was ensured through the use of trained abstractors, electronic abstraction instruments, and record reabstraction. Patients without valid Social Security numbers, receiving long-term hemodialysis, transferred to another hospital, or leaving against medical advice were excluded from the NHC cohorts, which consisted of 39 477 records in 1998 -1999 and 39 405 records in 2000 -2001. To evaluate the stability of the claims model over time, we examined the performance of the Medicare claims model using the other half of the 1998 MEDPAR data and data for each of years 1999, 2000, and 2001. For each year we created the study sample using the same approach as that used for the derivation cohort.
Outcome
The primary outcomes were hospital-and state-specific riskstandardized all-cause 30-day mortality, defined as death from any cause 30 days after the index admission date. We obtained mortality information from the Medicare enrollment files by linking unique patient identifiers.
Model Derivation: Patient Predictors of Mortality
We developed candidate variables for the Medicare claims model from the claims codes. Because there are Ͼ15 000 ICD-9-CM codes, we used the Hierarchical Condition Categories (HCC) to assemble clinically coherent codes into candidate variables. 8 This system, which includes 189 categories, was developed by physician and statistical consultants under a contract to CMS and is publicly available. The HCC candidate variables considered for this model were derived from the secondary diagnosis and procedure codes from the index hospitalization and from the principal and secondary diagnosis codes from hospitalizations, institutional outpatient visits, and physician encounters in the 12 months before the index hospitalization.
We conducted a clinical review of the candidate variables to exclude secondary diagnoses from the index hospitalization that may have represented complications rather than conditions present on admission. For example, because shock as a secondary code for the index hospitalization may not have been present at the time of admission, we did not include that code. We combined categories of HCC variables on the basis of clinical judgment and bivariate associations and eliminated candidate variables with a Ͻ1% frequency. Additional candidate variables included demographic (age, sex) and procedural factors (history of bypass surgery or percutaneous coronary intervention in the past year).
Model Development
Because of the natural clustering of the observations within hospitals, we estimated hierarchical generalized linear models (HGLM). 9 -11 We modeled the log-odds of mortality within 30 days of admission as a function of patient demographic and clinical characteristics and a random hospital-specific effect. This strategy accounts for within-hospital correlation of the observed outcomes and models the assumption that underlying differences in quality among the healthcare groups being evaluated lead to systematic differences in outcomes.
We first selected the covariates for the final claims model using a backward elimination procedure through the generalized linear model (GLM) with a logit link function approach. Because of the large number of patient observations, we chose an exit criterion of PϾ0.01. For each model, we calculated several indices for assessing model performance 12 at the patient level: the area under the receiver operating characteristic (ROC) curve, explained variation as measured by the generalized R 2 statistic, and the observed outcomes in strata defined by the lowest and highest deciles based on predictive probabilities. Large values for the ROC area, R 2 statistic, and a large difference in predicted probabilities between highest and lowest deciles provide evidence that the model has good discrimination. We further assessed model fit through examination of Pearson residuals. Finally, we reestimated the regression coefficients of the covariates identified from our backward elimination strategy using a HGLM.
Model Validation
Medical Record Model
We chose risk factors for the medical record model on the basis of the medical literature and clinical experience. 2, [13] [14] [15] [16] Unlike the claims data, some covariates could be missing for patients in the sample. We categorized continuous variables into categories using the clinically meaningful cut points and added a category for missing values where applicable. For discrete-valued variables, we included an additional level that indicated the variable was missing. This method of modeling missing data assumes that data are missing at random and permits inclusion of all available cases, although it is not as efficient as multiple imputation procedures. We computed measures of model fit and discrimination for the medical record model similar to those computed for the claims-based models.
Risk-Standardized Mortality Rates
We calculated risk-standardized mortality rates for each hospital using the estimated hospital-specific parameters from the respective hierarchical models. For this analysis we modeled the log-odds of mortality within 30 days of admission as a function of patient demographic and clinical characteristics and a random hospitalspecific effect. This strategy accounts for within-hospital correlation of the observed outcomes and models the assumption that there are underlying differences in quality among hospitals. These rates are obtained as the ratio of predicted to expected mortality, multiplied by the national unadjusted rate. 17 The ratio is predicted mortality in each hospital, given its patient mix and hospital-specific effect divided by the expected mortality in that hospital given the same patient mix and the average hospital-specific effect. 17 Although other researchers have calculated the ratio of observed to expected outcomes, we use the predicted rates to avoid several analytical problems that have been cited. 9, 11, 18 The expected outcome for each hospital is the number of 30-day deaths expected in the hospital if the hospital's patients were treated at a "reference" hospital. Operationally this was accomplished by regressing the risk factors on the mortality using all hospitals in our sample, applying the subsequent estimated regression coefficients to the patient characteristics observed in the hospital, and then summing. This is a form of indirect standardization. The predicted hospital outcome is the number of expected mortalities in the "specific" hospital and not at a reference hospital. Operationally this was accomplished by estimating a hospitalspecific random effect that represented baseline mortality risk within the hospital, applying the hospital-specific regression coefficients to the patient characteristics in the hospital, and then summing.
To assess the validity of the administrative data model, we repeated the aforementioned process, but, rather than calculating hospital-specific risk-standardized mortality rates, we calculated state-specific risk-standardized mortality rates and compared these rates with risk-standardized rates obtained from a medical record model. We conducted this analysis because medical record data were only available in sufficient numbers to perform a state-level comparison of the output of the 2 models. We used 2 approaches to examine the relationship between the risk-standardized rates obtained from administrative data and chart data. First, we estimated a linear regression equation describing the association between the 2 rates, weighting each state by the number of hospitalizations, and calculated the intercept and the slope of this equation. A slope close to 1 and an intercept close to 0 would provide evidence that the hospital rates from the 2 sources are very similar. Second, for each state we calculated the difference between the risk-standardized mortality rate based on the claims data and the medical record data and then summarized the distribution of these differences among the hospitals using the average, median, and maximum differences.
Stability of the Model Over Time
We compared the performance of the claims model over time in various validation cohorts, as described above. To assess whether we included too many risk factors in our final model, we calculated indices that quantify overfitting. Specifically, we used the coefficients estimated from the derivation model to predict the log-odds of mortality in the validation cohorts. This was accomplished by multiplying the observed risk factors in each validation cohort and summing over the covariates for a subject to obtain a mortality score. Using these scores for each subject, we then estimated a logistic regression model in which the outcome was observed mortality and the single covariate was the risk score. The intercept and slope obtained from this model are referred to as overfitting indices. If there is overfitting, we would expect the slopes to be different from 1 and the intercepts to be different from 0. We repeated this process for each validation dataset, each time calculating a risk score using the regression estimates from our derivation model.
After computing the overfitting statistics, in each validation dataset we recalibrated the model so that we used the same variables but fit the model to the data for each specific cohort. For each model, we calculated the same indices for assessing model performance 12 as in the derivation model.
All analyses were conducted with the use of SAS version 8.02 (SAS Institute Inc, Cary, NC). Models were fitted separately to each year of data. The hierarchical models were estimated with the use of the GLIMMIX macro in SAS.
The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results
Patient Characteristics and Administrative Model: Derivation Sample
The 1998 sample included 785 493 heart failure discharges from 5146 hospitals in the national fee-for-service administrative claims database, of which 9.6%, 13.0%, and 5.3% of discharges were excluded for age Ͻ65 years, incomplete information in the 12 months before admission, and length of stay of Յ1 day, respectively (Table 1) . Another 1.4% of the hospitalizations represented transfer in admission and were combined with the admission at the initial hospital to create an episode of care. In addition, 25.0% of the hospitalizations were repeat admissions. We randomly selected a single admission for each patient.
The derivation sample consisted of 222 424 cases with an unadjusted 30-day mortality rate of 12.1%. The mean age of the cohort was 79.6Ϯ7.7 years. The cohort included 59.3% women and 14.8% nonwhite patients. There were 5087 hospitals in the derivation cohort, with a median 
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annual number of Medicare heart failure hospitalizations of 28 (25th and 75th percentiles, 11 and 62, respectively). The observed mortality rate ranged from 0.0% to 100.0% across these hospitals, and the 25th, 50th, and 75th percentiles were 6.9%, 11.5%, and 16.7%, respectively. The claims model included 24 variables (2 demographic, 8 cardiovascular, and 14 comorbidity variables) ( Table 2) . The model had good discrimination, calibration, and fit (Table 3 ). The area under the ROC curve was 0.71. The observed mortality rate increased from 3.0% in the lowest predicted decile to 28.5% in the highest predicted decile, a range of 24.5%. The adjusted R 2 was 0.10. Figure 1A and 1B shows the distributions of the standardized 30-day mortality rates overall and stratified by hospital heart failure volume. The 25th and 75th percentiles were 11.6% and 12.8%, respectively. The 95th percentile was 14.2%, and the 5th percentile was 10.5%.
Medical Record Validation
The NHC validation sample contained 46 700 hospitalizations from 4285 hospitals in 50 states and a crude 30-day mortality rate of 11.9%. The medical record comparison model in this cohort included 28 variables ( Table 4 ). The area under the ROC curve was 0.78. The observed mortality rate ranged from 1.8% in the lowest predicted decile to 42.4% in the highest. As expected, the explained variation was higher in the chart-based model (R 2 was 0.22) than in the claimsbased model.
In this cohort the administrative model had an area under the ROC curve of 0.70, an observed mortality rate ranging from 2.9% in the lowest predicted decile to 28.4% in the highest predicted decile, and an adjusted R 2 of 0.09. The estimated state-specific standardized mortality rates derived from each model are displayed in Figure 2 . The slope of the weighted regression line of the statespecific mortality rates is 0.76 (SEϭ0.04), and the intercept is 0.03 (SEϭ0.004). The correlation coefficient of the standardized mortality rates from the 2 models is 0.95 (SEϭ0.02). The median difference between the models in the state-specific risk-standardized mortality rates was Ͻ0.001 (25th percentile, Ϫ0.003; 75th percentile, 0.02; 10th percentile, Ϫ0.006; 90th percentile, 0.004).
Model Performance in the Administrative Validation Set
In each validation cohort, the model fit was similar to that of the derivation cohort (Table 3 ). These comparisons spanned 3 years of Medicare admissions for heart failure. The unadjusted mortality ranged from 11.5% to 12.2% across years of data. The percent explained variation ranged from 0.09 to 0.10, and the area under the ROC curves was 0.70.
Discussion
We developed an administrative claims-based model for calculating 30-day case mix-adjusted heart failure mortality rates in Medicare fee-for-service patients. This model has recently been endorsed by the National Quality Forum. Although the deficiencies of administrative data are well known, 20 the risk-standardized estimates from this model at the state level are highly correlated with the estimates obtained from a medical record model. Thus, for the purposes of profiling, the claims model was a very good surrogate for the medical record model, and the model was very stable over time. The medical record model we used had good discrimination, rivaling a model that was recently published by a Canadian group. 2 We note that our comparison between data sources focused on risk-standardized estimates; investigators who wish to use different functions of the estimates, such as the percentage of hospitals falling into a particular quantile, will need to undertake an assessment of the comparability of the 2 data sources.
Importantly, the claims model only includes information about the patients that is known on admission. Secondary diagnoses in administrative claims may represent conditions present on admission or those that develop during the hospitalization. Thus, we omitted secondary diagnostic codes that may have represented complications, avoiding a scenario of making a hospital with a high rate of complications appear to be admitting patients with greater illness.
Another model using this methodology was developed for assessing the performance of the care of acute myocardial infarction. 19 The findings in this study are similar, providing evidence that an administrative model can produce results that are comparable to those of a medical record model. In the case of acute myocardial infarction, we were able to perform the comparison of the claims model with the medical record model at the hospital level, using data from the Cooperative Cardiovascular Project. 22 For our study we were only able to compare performance at the state level because of the availability of data. At a hospital level there may be less agreement, but in the hospital-level analysis of acute myocardial infarction the findings were very similar. We counted only a single admission from each patient in each time period that was evaluated. Although this approach resulted in the loss of some information, it was necessary because mortality rates would be associated with readmission rates if all readmissions were included. Prior studies have indicated very high readmission rates for Medicare patients discharged after an episode of heart failure. 23 An important aspect of our model is that it is in the public domain. Other publicly reported models of heart failure outcomes are proprietary. 24 It is not possible to determine which variables are included or how well the model performs. Shielding this information from the public ensures that the validity of these models cannot be evaluated.
We employed hierarchical modeling in developing this model, which accounts for the clustering of the data (ie, patients within hospitals). 10, 25, 26 Patients within hospitals have characteristics that are more highly correlated than patients in different hospitals. The relatedness of the observations can lead to underestimation of the SEs and cause the false appearance of statistically significant differences. In addition, hierarchical modeling can take into account differences in the amount of information provided by each hospital and allow small-volume hospitals to be retained in the analysis.
An important issue is whether 30-day mortality is a suitable metric for evaluating hospital performance for patients with heart failure. For some patients with end-stage heart failure, death is not an adverse event but rather the inevitable consequence of a long, chronic illness. For some patients who die, quality of care plays no role. However, our assumption is that most patients hospitalized with heart failure prefer to survive the hospitalization. Moreover, quality of care is associated with the risk of dying. Finally, the fairest way to assess hospital outcomes is to look at a standardized period of time that is fairly proximate to the time of the initial hospitalization. For these reasons, we chose to use 30-day mortality. We were not able to include resuscitation status in this model. However, even if it were available it is not clear that it should be used as a covariate. The designation of do-not-resuscitate (DNR) is distinct from a decision to provide comfort care only. Patients with DNR may want high-quality care that will enhance the likelihood that they will survive. What DNR means for many individuals is that they do not want extraordinary means to keep them alive should their condition worsen. Thus, whether patients with a DNR status should not be considered in this assessment is not clear. We need a marker for patients who are admitted to the hospital for palliative care and for whom survival is not a goal of treatment. In the absence of this type of information, it will be difficult to incorporate the treatment goals into the outcomes assessment, which is a limitation of any such measure. For this to be a problem, there would have to be marked differences among the hospitals in the number of patients admitted who prefer comfort care only. We anticipate that this population is very small in comparison to the patients admitted who prefer high-quality care that will increase their likelihood of at least short-term survival.
We also note that in the linked sample, explained variation was low: 9% with administrative data and 22% with medical record data. Even the best models that predict outcomes in medicine have a substantial amount of unexplained variation. This unexplained variation is a result of unmeasured risk factors, quality of care, and random variation. In the medical record model, which is used for validation of the administrative claims model, we have included the risk factors that are considered most important for early mortality. It is possible that novel risk factors will be identified or that some other unmeasured risk factors might have added incrementally to the model, but it is unlikely that they would have markedly increased the explained variation. We are left with the inference that much of the unexplained variation is the result of the care that was provided and random variation.
Administrative data from Medicare have limitations but are the only currently available national data that can assess hospital outcomes for heart failure. Approximately 70% of heart failure hospitalizations occur in patients aged Ն65 years. As a result, Medicare data are highly representative of this population. More timely chart information would be preferable, but the burden on institutions would be considerable with current technology.
Some hospitals accept in referral many patients with end-stage heart failure for transplantation or other hightechnology interventions. Medicare patients, however, are not generally candidates for these approaches, and therefore the expectation is that heart failure centers will not suffer from adverse selection when only Medicare patients are considered. Improving routinely collected data holds great promise for enhancing our ability to track outcomes, to elevate risk adjustment approaches, and to avoid manipulation of coding. For now, we only have administrative data with which to perform this type of profiling.
This model was developed on the basis of the heart failure codes available during the time periods assessed. We could not validate the codes in the administrative dataset, but studies suggest that they have a very high specificity and positive predictive value. 27 The introduction of new codes is unlikely to affect these models because they would involve a redistribution of patients but would not be expected to move a patient out of a heart failure code. Nevertheless, these models are expected to undergo continual evaluation with The direction of the coefficients in the models deserves comment. Several variables, such as hypertension, history of procedures, and unstable angina, have negative coefficients. The direction of these coefficients is consistent with the chart review model except for unstable angina, which was not included. These variables may be related to cardiac function (independent of ejection fraction, which is included in the medical record model) or may be a marker for other patient characteristics that are associated with a favorable prognosis. More work is necessary to understand how these factors may mediate their association. In addition, one variable, diabetes, has a positive coefficient in the administrative model and a negative coefficient in the medical record model. It is important to note that the variables are very different. In the administrative claims we determined whether there had been a claim in the prior year for diabetes. This may identify a person with more severe diabetes and someone who is seeking care for the condition. In the medical record we sought any documentation of diabetes at any time and had no information on whether the patients were seeking care for it and did not require that they were being treated for it. The differences in the definitions and in the associated covariates likely led to the different directions of the ␤-coefficient of the covariate.
Another important consideration is that the claims models depend on data that are available only from CMS. The generalizability of the findings to other populations cannot be tested. Nevertheless, the vast majority of patients admitted to the hospital with heart failure are in the Medicare population, in which fee-for-service is the most common form of coverage. The ability to profile the performance of hospitals by their experience with this large patient group is useful. However, this approach may not represent performance with other groups of patients with heart failure.
In conclusion, we developed a model using administrative claims data that is suitable for profiling hospital heart failure outcomes. The model is in the public domain and demonstrates consistent performance over time. In addition, it produces results that can serve as a surrogate for those from a medical record model. Despite the limitations of currently available data, this model may be a valuable tool in assessing the outcomes achieved by states and hospitals in caring for patients with heart failure.
